Free Trial

Repare Therapeutics (RPTX) SEC Filings & 10K Form

$3.48
+0.13 (+3.88%)
(As of 05/31/2024 ET)

Recent Repare Therapeutics SEC Filings

DateFilerForm TypeView
05/24/2024
3:06 PM
Repare Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/26/2024
3:14 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
8:27 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
8:28 PM
Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
8:30 PM
Forte Steve (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
8:31 PM
Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:54 PM
Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:56 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:57 PM
Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:59 PM
Forte Steve (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
11:37 AM
Forte Steve (Reporting)
Repare Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
1:50 PM
Repare Therapeutics (Subject)
Segal Lloyd Mitchell (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
6:25 PM
Repare Therapeutics (Subject)
Segal Lloyd Mitchell (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:23 PM
Koehler Maria (Reporting)
Repare Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:23 PM
Repare Therapeutics (Subject)
Zinda Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
8:02 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
8:04 PM
Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
8:06 PM
Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:10 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:15 AM
Repare Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
8:02 PM
Blue Owl Capital Holdings LP (Filed by)
Repare Therapeutics (Subject)
Form SC 13G
02/14/2024
7:54 AM
Deep Track Capital, LP (Filed by)
Repare Therapeutics (Subject)
Form SC 13G/A
01/29/2024
3:01 PM
ARK Investment Management LLC (Filed by)
Repare Therapeutics (Subject)
Form SC 13G/A
01/25/2024
1:29 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
3:05 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
3:19 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
3:52 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Repare Therapeutics (Subject)
Form SC 13D/A
11/17/2023
3:54 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
6:20 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:05 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:10 AM
Repare Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2023
4:20 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Repare Therapeutics (Subject)
Form SC 13D
11/03/2023
4:37 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2023
4:15 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2023
8:47 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
6:56 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2023
3:17 PM
Molineaux Susan (Reporting)
Repare Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/12/2023
3:20 PM
Bonita David P (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:22 PM
Civik Thomas (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
4:18 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2023
3:55 PM
Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Dems have chosen Biden replacement? (Ad)

On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.

See who it is HERE.
06/07/2023
3:31 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2023
3:25 PM
Repare Therapeutics (Subject)
Zinda Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:RPTX) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners